Inhibition of virus induced Aggravation of childhood asthma by Salmeterol/Fluticasone Propionate Combination(SFC)

Phase 3

Recruiting

• Conditions: Asthma; asthma

• Registration Number: JPRN-jRCTs031180304
• Lead Sponsor: Yoshihara Shigemi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Physician diagnosed asthma(
More than 3 wheeze episode)
More than 2 asthma attacks for 8 weeks
LTRA is taken for more than 1month as a controller

Exclusion Criteria

SFC or Fluticasone is used as a controller
Patients has respiratory diseases except asthma

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In patients with a common cold, asthma control was significantly more effective for those treated with SFC compared to treatment with Fluticasone

Secondary Outcome Measures

Name	Time	Method
In 12th week SFC group will show higher Best ACT P score and QOL score than fluticasone group.<br>SFC group will less frequently to use b stimulator and less frequently to visit ER department.